| pubmed-article:21419519 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21419519 | lifeskim:mentions | umls-concept:C0027651 | lld:lifeskim |
| pubmed-article:21419519 | lifeskim:mentions | umls-concept:C0005684 | lld:lifeskim |
| pubmed-article:21419519 | lifeskim:mentions | umls-concept:C0242957 | lld:lifeskim |
| pubmed-article:21419519 | lifeskim:mentions | umls-concept:C0069515 | lld:lifeskim |
| pubmed-article:21419519 | lifeskim:mentions | umls-concept:C1514559 | lld:lifeskim |
| pubmed-article:21419519 | lifeskim:mentions | umls-concept:C0034897 | lld:lifeskim |
| pubmed-article:21419519 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:21419519 | lifeskim:mentions | umls-concept:C0441800 | lld:lifeskim |
| pubmed-article:21419519 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:21419519 | pubmed:dateCreated | 2011-4-4 | lld:pubmed |
| pubmed-article:21419519 | pubmed:abstractText | To evaluate the prognostic value of HER2 expression in non-muscle invasive bladder transitional cell carcinoma (TCC) with special emphasis in the high grade population. MATERIALS AND METHODS (PATIENTS): Tissue microarrays (TMA) were performed with representative TUR-B specimens from 84 patients with non-muscle invasive bladder TCC (40 pT1GII and 44 pT1GIII) treated in our institution. Depth of invasion and grade were uniformly assigned by the same pathologist who performed blind immunohistochemical analysis with Hercep test: 3+ was considered strong positive HER2 overexpression. Other clinico-pathological variables were also assessed. | lld:pubmed |
| pubmed-article:21419519 | pubmed:language | spa | lld:pubmed |
| pubmed-article:21419519 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21419519 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21419519 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21419519 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21419519 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21419519 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21419519 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:21419519 | pubmed:issn | 1699-7980 | lld:pubmed |
| pubmed-article:21419519 | pubmed:author | pubmed-author:AmeurAA | lld:pubmed |
| pubmed-article:21419519 | pubmed:author | pubmed-author:AbbasLL | lld:pubmed |
| pubmed-article:21419519 | pubmed:author | pubmed-author:BouzidiAA | lld:pubmed |
| pubmed-article:21419519 | pubmed:author | pubmed-author:HajjiFF | lld:pubmed |
| pubmed-article:21419519 | pubmed:author | pubmed-author:GhadouaneMM | lld:pubmed |
| pubmed-article:21419519 | pubmed:author | pubmed-author:JananeAA | lld:pubmed |
| pubmed-article:21419519 | pubmed:author | pubmed-author:IsmailT OTO | lld:pubmed |
| pubmed-article:21419519 | pubmed:author | pubmed-author:ElondoJ CJC | lld:pubmed |
| pubmed-article:21419519 | pubmed:copyrightInfo | Copyright © 2010 AEU. Published by Elsevier Espana. All rights reserved. | lld:pubmed |
| pubmed-article:21419519 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21419519 | pubmed:volume | 35 | lld:pubmed |
| pubmed-article:21419519 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21419519 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21419519 | pubmed:pagination | 189-94 | lld:pubmed |
| pubmed-article:21419519 | pubmed:meshHeading | pubmed-meshheading:21419519... | lld:pubmed |
| pubmed-article:21419519 | pubmed:meshHeading | pubmed-meshheading:21419519... | lld:pubmed |
| pubmed-article:21419519 | pubmed:meshHeading | pubmed-meshheading:21419519... | lld:pubmed |
| pubmed-article:21419519 | pubmed:meshHeading | pubmed-meshheading:21419519... | lld:pubmed |
| pubmed-article:21419519 | pubmed:meshHeading | pubmed-meshheading:21419519... | lld:pubmed |
| pubmed-article:21419519 | pubmed:meshHeading | pubmed-meshheading:21419519... | lld:pubmed |
| pubmed-article:21419519 | pubmed:meshHeading | pubmed-meshheading:21419519... | lld:pubmed |
| pubmed-article:21419519 | pubmed:meshHeading | pubmed-meshheading:21419519... | lld:pubmed |
| pubmed-article:21419519 | pubmed:meshHeading | pubmed-meshheading:21419519... | lld:pubmed |
| pubmed-article:21419519 | pubmed:meshHeading | pubmed-meshheading:21419519... | lld:pubmed |
| pubmed-article:21419519 | pubmed:meshHeading | pubmed-meshheading:21419519... | lld:pubmed |
| pubmed-article:21419519 | pubmed:meshHeading | pubmed-meshheading:21419519... | lld:pubmed |
| pubmed-article:21419519 | pubmed:meshHeading | pubmed-meshheading:21419519... | lld:pubmed |
| pubmed-article:21419519 | pubmed:meshHeading | pubmed-meshheading:21419519... | lld:pubmed |
| pubmed-article:21419519 | pubmed:meshHeading | pubmed-meshheading:21419519... | lld:pubmed |
| pubmed-article:21419519 | pubmed:meshHeading | pubmed-meshheading:21419519... | lld:pubmed |
| pubmed-article:21419519 | pubmed:meshHeading | pubmed-meshheading:21419519... | lld:pubmed |
| pubmed-article:21419519 | pubmed:meshHeading | pubmed-meshheading:21419519... | lld:pubmed |
| pubmed-article:21419519 | pubmed:meshHeading | pubmed-meshheading:21419519... | lld:pubmed |
| pubmed-article:21419519 | pubmed:meshHeading | pubmed-meshheading:21419519... | lld:pubmed |
| pubmed-article:21419519 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21419519 | pubmed:articleTitle | [Evaluation of HER2 protein overexpression in non-muscle-invasive bladder cancer with emphasis on tumour grade and recurrence]. | lld:pubmed |
| pubmed-article:21419519 | pubmed:affiliation | Departamento de Urología, Hospital Militar Universitario Mohamed V, Rabat, Marruecos. a.janane@yahoo.fr | lld:pubmed |
| pubmed-article:21419519 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21419519 | pubmed:publicationType | English Abstract | lld:pubmed |
| entrez-gene:2064 | entrezgene:pubmed | pubmed-article:21419519 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:21419519 | lld:entrezgene |
